All In Biotech

Drug Trial Radar · NCT03670953

A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations

A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in Parkinson's Disease Patients With Motor Fluctuations

Last checked: Nov 19, 2026Latest source record: Feb 9, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 630 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

630

Actual

Start

Nov 6, 2018

Primary completion

Jun 15, 2021

Study completion Jun 15, 2021

Sponsor

Lead sponsor
Impax Laboratories, LLCIndustry
Sponsor type
Industry
First posted
Sep 14, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and efficacy of IPX203 (carbidopa and levodopa) extended-release capsules (IPX203 ER CD-LD) in comparison to immediate release (IR) CD-LD in the treatment of CD-LD-experienced participants with Parkinson's disease (PD) who have motor fluctuations.

Conditions

  • Parkinson's Disease (Disorder)

Interventions

  • IR CD-LDDrug

    Active comparator - IR CD-LD

  • IPX203 ER CD-LDDrug

    Investigational formulation - ER CD-LD

  • Placebo Matching IPX203Other

    Double dummy placebo capsules

  • Placebo Matching IR CD-LDOther

    Double dummy placebo tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change From Baseline in "Good on" Time Per Day at Week 20/Early Termination (ET)Time frame: Baseline (Week 7) and Week 20/ET

Locations

108 sites in 8 countries. Site status is shown where the registry gives one.

  • Xenoscience, Inc. (102)

    Phoenix, Arizona

  • St. Joseph's Hospital & Medical Center/ Barrow Neurological Institute (156)

    Phoenix, Arizona

  • Clinical Trials, Inc. (113)

    Little Rock, Arkansas

  • University of Arkansas for Medical Sciences (117)

    Little Rock, Arkansas

  • Loma Linda University Health Care, Department of Neurology (137)

    Loma Linda, California

  • Keck School of Medicine of USC/University of Southern California (106)

    Los Angeles, California

  • Hoag Memorial Hospital Presbyterian (134)

    Newport Beach, California

  • SC3 Research - Pasadena (148)

    Pasadena, California

  • SC3 Research - Reseda (146)

    Reseda, California

  • University of Colorado Hospital Anschutz Outpatient Pavilion (120)

    Aurora, Colorado

  • Rocky Mountain Movement Disorders Center (116)

    Englewood, Colorado

  • Christiana Care Neurology Specialists (153)

    Newark, Delaware

  • JEM Research Institute (136)

    Atlantis, Florida

  • Visionary Investigators Network (168)

    Aventura, Florida

  • University of Miami-UHealth at Boca Raton (152)

    Boca Raton, Florida

  • Parkinson's Disease and Movement Disorders Center of Boca Raton (121)

    Boca Raton, Florida

  • MD Clinical (111)

    Hallandale, Florida

  • Infinity Clinical Research (104)

    Hollywood, Florida

  • University of Florida Health Science Center(129)

    Jacksonville, Florida

  • Neurology Associates, P.A. (125)

    Maitland, Florida

  • University of Miami (149)

    Miami, Florida

  • Medical Professional Clinical Research Center, INC (163)

    Miami, Florida

  • Parkinsons's Disease Treatment Center of Southwest Florida (131)

    Port Charlotte, Florida

  • Infinity Clinical Research, LLC (105)

    Sunrise, Florida

  • University of South Florida (114)

    Tampa, Florida

  • Premiere Research Institute at Palm Beach Neurology (174)

    West Palm Beach, Florida

  • Charter Research (166)

    Winter Park, Florida

  • Emory Brain Health Center (110)

    Atlanta, Georgia

  • NeuroStudies.net, LLC (155)

    Decatur, Georgia

  • Northwestern Medical Group Neurology Clinic(145)

    Chicago, Illinois

  • Central DuPage Hospital (151)

    Winfield, Illinois

  • Indiana University Health Neuroscience Center (164)

    Indianapolis, Indiana

  • University of Kansas Medical Center (118)

    Kansas City, Kansas

  • Quest Research Institute (103)

    Farmington Hills, Michigan

  • Henry Ford West Bloomfield Hospital (100)

    West Bloomfield, Michigan

  • Struthers Parkinson's Center (130)

    Golden Valley, Minnesota

  • Washington University (109)

    St Louis, Missouri

  • Cleveland Clinic Lou Ruvo Center for Brain Health (142)

    Las Vegas, Nevada

  • Roseman Medical Research Institute/Roseman Medical Group (154)

    Las Vegas, Nevada

  • Albany Medical College (139)

    Albany, New York

Showing 40 of 108 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.